BRCA1 and neoplasm: The national genomic test directory for NHS England allows all patients diagnosed with epithelial ovarian cancer to undergo germline BRCA1/2 testing, and all patients eligible for first-line treatment, who have been diagnosed with high-grade ovarian cancer, to undergo tumour BRCA1/2 testing (as part of ‘tumour HRD testing’) [20,22].